122 related articles for article (PubMed ID: 37052432)
21. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
Tian X; Zhang Z
IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
[TBL] [Abstract][Full Text] [Related]
22. Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR-140-3p/SKA2 axis.
Dou D; Ren X; Han M; Xu X; Ge X; Gu Y; Wang X; Zhao S
Mol Oncol; 2021 Feb; 15(2):697-709. PubMed ID: 33244865
[TBL] [Abstract][Full Text] [Related]
23. miR-125a-3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor-positive breast cancer.
Zheng L; Meng X; Li X; Zhang Y; Li C; Xiang C; Xing Y; Xia Y; Xi T
FASEB J; 2018 Feb; 32(2):588-600. PubMed ID: 28939591
[TBL] [Abstract][Full Text] [Related]
24. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
[TBL] [Abstract][Full Text] [Related]
25. miR-542-3p targets sphingosine-1-phosphate receptor 1 and regulates cell proliferation and invasion of breast cancer cells.
Wu HX; Wang GM; Lu X; Zhang L
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):108-114. PubMed ID: 28121348
[TBL] [Abstract][Full Text] [Related]
26. Estrogen upregulates MICA/B expression in human non-small cell lung cancer through the regulation of ADAM17.
Ren J; Nie Y; Lv M; Shen S; Tang R; Xu Y; Hou Y; Zhao S; Wang T
Cell Mol Immunol; 2015 Nov; 12(6):768-76. PubMed ID: 25363527
[TBL] [Abstract][Full Text] [Related]
27. ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis.
Li X; Zou ZZ; Wen M; Xie YZ; Peng KJ; Luo T; Liu SY; Gu Q; Li JJ; Luo ZY
Mol Med; 2020 Nov; 26(1):109. PubMed ID: 33187481
[TBL] [Abstract][Full Text] [Related]
28. MiR-338-3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17.
Chen JT; Yao KH; Hua L; Zhang LP; Wang CY; Zhang JJ
Int J Clin Exp Pathol; 2015; 8(9):10922-8. PubMed ID: 26617808
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of NRARP exerts anti-tumor activities in the breast tumor cells depending on Wnt/β-catenin-mediated signals: The role of miR-130a-3p.
Poodineh J; Sirati-Sabet M; Rajabibazl M; Ghasemian M; Mohammadi-Yeganeh S
Chem Biol Drug Des; 2022 Sep; 100(3):334-345. PubMed ID: 35797350
[TBL] [Abstract][Full Text] [Related]
30. miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2.
Wang H; Hu X; Yang F; Xiao H
Oncol Res; 2021 Sep; 28(7):731-744. PubMed ID: 33419488
[TBL] [Abstract][Full Text] [Related]
31. MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.
Zhang Y; Wang Y; Wei Y; Li M; Yu S; Ye M; Zhang H; Chen S; Liu W; Zhang J
Sci Rep; 2015 Oct; 5():15424. PubMed ID: 26487539
[TBL] [Abstract][Full Text] [Related]
32. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.
Lee YM; Lee JY; Ho CC; Hong QS; Yu SL; Tzeng CR; Yang PC; Chen HW
Breast Cancer Res; 2011; 13(6):R116. PubMed ID: 22113133
[TBL] [Abstract][Full Text] [Related]
33. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2.
Tan S; Ding K; Li R; Zhang W; Li G; Kong X; Qian P; Lobie PE; Zhu T
Breast Cancer Res; 2014 Apr; 16(2):R40. PubMed ID: 24735615
[TBL] [Abstract][Full Text] [Related]
34. M2 Macrophage-Derived Exosomes Regulate miR-199a-3p Promoter Methylation Through the LINC00470-Mediated myc/DNMT3a Axis to Promote Breast Cancer Development.
Ma D; Wu J; Chen C; Niu Y; Ji K; Xiao Y; Guan Q
Biochem Genet; 2023 Oct; ():. PubMed ID: 37851210
[TBL] [Abstract][Full Text] [Related]
35. Circular RNA circ_0000518 promotes breast cancer progression through the microRNA-1225-3p/SRY-box transcription factor 4 pathway.
Shujuan K; Zhongxin L; Jingfang M; Zhili C; Wei W; Liu Q; Li Y
Bioengineered; 2022 Feb; 13(2):2611-2622. PubMed ID: 35112991
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-588 is downregulated and may have prognostic and functional roles in human breast cancer.
Yu M; Zhang X; Li H; Zhang P; Dong W
Med Sci Monit; 2017 Nov; 23():5690-5696. PubMed ID: 29187727
[TBL] [Abstract][Full Text] [Related]
37. MiR-338-3p inhibits cell migration and invasion in human hypopharyngeal cancer via downregulation of ADAM17.
Hong Y; Chen X; Liang Z; Xu Z; Li Y; Pan Y
Anticancer Drugs; 2020 Oct; 31(9):925-931. PubMed ID: 32889897
[TBL] [Abstract][Full Text] [Related]
38. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G
Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
[TBL] [Abstract][Full Text] [Related]
40. microRNA-140-3p modulates invasiveness, motility, and extracellular matrix adhesion of breast cancer cells by targeting syndecan-4.
Onyeisi JOS; Greve B; Espinoza-Sánchez NA; Kiesel L; Lopes CC; Götte M
J Cell Biochem; 2021 Oct; 122(10):1491-1505. PubMed ID: 34180077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
